ASSET | DATE | % RETURN |
---|---|---|
Eyepoint Pharmaceuticals (EYPT) | 11/28/2023 - 12/10/2023 | 210.88% |
Altimmune (ALT) | 11/28/2023 - 12/10/2023 | 114.57% |
Bitfarms (BITF) | 11/28/2023 - 12/10/2023 | 110.57% |
MBIA (MBI) | 11/28/2023 - 12/10/2023 | 82.09% |
Spyre Therapeutics (SYRE) | 11/28/2023 - 12/10/2023 | 81.41% |
DeFi Development (DFDV) | 11/28/2023 - 12/10/2023 | 79.96% |
Terns Pharmaceuticals (TERN) | 11/28/2023 - 12/10/2023 | 71.65% |
Solid Biosciences LLC (SLDB) | 11/28/2023 - 12/10/2023 | 68.11% |
Absci (ABSI) | 11/28/2023 - 12/10/2023 | 64.29% |
Hovnanian Enterprises (HOV) | 11/28/2023 - 12/10/2023 | 54.58% |
Satellogic V (SATL) | 11/28/2023 - 12/10/2023 | 53.33% |
Bit Digital (BTBT) | 11/28/2023 - 12/10/2023 | 49.79% |
Travere Therapeutics (TVTX) | 11/28/2023 - 12/10/2023 | 48.2% |
Mobilicom Limited Warrants (MOBBW) | 11/28/2023 - 12/10/2023 | 45.79% |
Nurix Therapeutics (NRIX) | 11/28/2023 - 12/10/2023 | 45.27% |
Canopy Growth (CGC) | 11/28/2023 - 12/10/2023 | 44.74% |
Lendingtree (TREE) | 11/28/2023 - 12/10/2023 | 44.28% |
HIVE Blockchain Technologies (HIVE) | 11/28/2023 - 12/10/2023 | 43.84% |
Pharvaris (PHVS) | 11/28/2023 - 12/10/2023 | 43.62% |
Beyond (BYON) | 11/28/2023 - 12/10/2023 | 43.16% |
Gossamer Bio (GOSS) | 11/28/2023 - 12/10/2023 | 41.68% |
NRx Pharmaceuticals (NRXPW) | 11/28/2023 - 12/10/2023 | 41.44% |
ADC Therapeutics (ADCT) | 11/28/2023 - 12/10/2023 | 40.69% |
Oatly Group AB ADR (OTLY) | 11/28/2023 - 12/10/2023 | 40.51% |
Arvinas (ARVN) | 11/28/2023 - 12/10/2023 | 40.4% |